Picture of AtriCure logo

ATRC AtriCure News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

AtriCure Inc reports results for the quarter ended in March - Earnings Summary

* AtriCure Inc  ATRC.OQ  reported a quarterly adjusted loss
of 23
cents​​ per share for the quarter ended in March. The mean
expectation of seven analysts for the quarter was for a loss
of 34 cents per share.
    * Revenue rose 25.4% to $93.49 million from a year ago;
analysts
expected $87.53 million. 
    * AtriCure Inc's reported EPS for the quarter was a loss
of 14
cents​.
    * The mean earnings estimate of analysts had fallen by
about 32.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AtriCure Inc shares had risen by 8.9% this quarter and
gained 1.7% so far this year.
    * The company reported a quarterly loss of $6.48 million.
    * Wall Street's median 12-month price target for AtriCure
Inc is
$55.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
2 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.34          -0.23          Beat
 Dec. 31 2022      -0.18          -0.09          Beat
 Sep. 30 2022      -0.25          -0.27          Missed
 Jun. 30 2022      -0.29          -0.32          Missed

Recent news on AtriCure

See all news